Press Release
viemaa Revolutionizes Hair Care with a Patented Biomimetic Cuticle Technology
Innovative hair care brand merges science with style to formulate products that repair and strengthen all hair types, and empower women with confidence, self-expression, and noticeably healthy hair. Read More
Press Release
Black Book Research Unveils 2025’s Top-Rated Population Health & Value-Based Care Vendors: AI, Interoperability, and ROI Take Center Stage
New Industry KPIs for Evaluating PHM & VBC IT Vendors Prioritize AI-Driven Insights, Workflow Automation, and Real-World Clinical Impact - Top 2025 Vendors Recognized for Effectiveness and Client Experience Read More
Press Release
Ondas and Volatus Aerospace Forge Strategic Partnership to Elevate Border Surveillance with Advanced Drone Technologies
Strategic partnership's multi-modal approach significantly enhances homeland security agencies' ability to detect and mitigate threats before they escalate, revolutionizing border security with persistent remote aerial operations and emergency response Volatus' extensive sales, marketing, field support, and services capabilities extend Ondas' market reach and accelerate market penetration for the Optimus System The Optimus System to be deployed as drone infrastructure for completely remote, autonomous operations providing aerial security and intelligence for sensitive locations, critical operations and assets Read More
Press Release
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis
- This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis - - The Company recently entered into a Clinical Trial Collaboration Agreement with Revance to study DMT410 for the treatment of axillary hyperhidrosis - - The Company also has an issued patent in Japan covering their DMT410 program for the treatment of hyperhidrosis - Read More
Press Release
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete Test results support the next development step with Phase 1clinical trial expected to commence in April Provides Summary of Expected 2025 Milestones Read More
Press Release
DOJ Makes Major Announcement - a Major Boost for MMJ'S Cannabis Research and DEA Accountability
The Department of Justice (DOJ) has announced that it will no longer defend statutory protections that currently shield Administrative Law Judges (ALJs) from removal. This significant shift is expected to bolster MMJ International Holdings' ongoing lawsuit against the Drug Enforcement Administration (DEA), which has been criticized for stalling MMJ's application to cultivate pharmaceutical-grade marijuana for medical research. Read More
Press Release
